ARKK Holdings of Exact Sciences Corp. (EXAS) - Updated Daily
Liquid BiopsyGenomicsGenetic Testing
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 6.39% | $12.02b |
| 🏋🏿♂️Weight Rank In ARKK | 🌏Country |
| 5 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 3 | $106.19 |
| 🎫ARK Ownership Percent | |
| 3.96% | |
| Description | |
|---|---|
| A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. | |
| Website | |
| www.exactsciences.com |
Other ETFs That Hold EXAS
Research Notes and Commentary for EXAS
November 3, 2021
November 1-3: ARK Trades and Storylines
Trading Floor
February 17, 2021
February 17, 2021: ARK Trades and Storylines
Trading Floor
January 25, 2021
Ark Trades and Storylines
Trading Floor
January 14, 2021
Webinar Takeaways: Simon Barnett on Liquid Biopsies and Early Cancer Detection
Trading Floor
December 16, 2020
Exact Science (EXAS) And The Science Of Poop
Trading Floor
March 22, 2020